A Resource for Healthcare and Social Services Professionals
December 9, 2021
12:00 pm–1:30 pm ET
This training will review strategies to reduce non-communicable infectious diseases in patients that use injection drugs. Safer injection technique, equipment needed for safe injection, and strategies to reduce skin and soft tissue infections (SSTIs) will be reviewed. Additional education will be provided about basics of wound and abscess care for patients to prevent worsening SSTIs.
Via Zoom
The Harm Reduction Series is designed to provide caregivers and providers with information on best practices for caring for individuals who are actively using substances. The education series will teach ways to expand the treatment continuum to include engaging and keeping people safe when they are actively using substances including alcohol, opioids, stimulants, and tobacco. The series is designed for a broad range of audiences and each module will be presented with an expert from the community to provide insight regarding strategies for engagement and implementation.
This training will review strategies to reduce non-communicable infectious diseases in patients that use injection drugs. Safer injection technique, equipment needed for safe injection, and strategies to reduce skin and soft tissue infections (SSTIs) will be reviewed. Additional education will be provided about the basics of wound and abscess care for patients to prevent worsening SSTIs.
The entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction.
Guest Speaker
Raagini Jawa, MD, MPH
Dr. Jawa is a Clinical Instructor of Medicine at Boston University School of Medicine, board certified in Internal Medicine and Infectious Disease and an addiction expert at Boston Medical Center and Boston University School of Medicine. Dr. Jawa’s research interests focus on the intersection of Infectious Disease and addiction including enhancing and integrating harm reduction services for individuals with substance use disorders, implementing behavioral interventions to prevent skin and soft tissue infections among people who inject drugs, integrating overdose prevention and HIV prevention services within medical systems. Clinically, she provides HIV primary care and office based addiction treatment in the Center for Infectious Disease at Boston Medical Center, and attends on the Addiction Consult Service at Boston Medical Center.
Boston Medical Center Grayken Center for Addiction, Department of Public Health, Bureau of Substance Addiction Services.
Boston Medical Center grants 1.50 hours to all RNS who attend and complete the evaluation. Boston Medical Center is approved as a provider of continuing professional development by the American Nurses Association, Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Boston University School of Medicine designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Boston University School of Social Work which is authorized through the MA state board of Social Work to provide 1.50 CE Credit Hours.
Massachusetts Mental Health Counselors Association, Inc. (MaMHCA) grants 1.50 LMHC CE Credits to LMHCs that attend this activity.
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.